In the last few weeks, QLT stock price moving nicely.
posted on
Aug 05, 2009 06:40PM
I don't own but, this stock seems to be building through excellent sales.
Prostate drug sales lift QLT
Vancouver — Drug-maker QLT Inc. on July 28/09 said profits and revenues rose in the second quarter of 2009 due largely to increased sales of the prostate cancer drug Eligard.
The Vancouver-based drug maker reported profit of $8.6-million (U.S.) or 16 cents per share for the quarter ended June 30, reversing a year-earlier loss of $7.4-million or 10 cents per share.
